Silk Road Medical, Inc
SILK
NASDAQ
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Net Income | -56.54M | -53.42M | -55.74M | -55.35M | -52.88M |
Total Depreciation and Amortization | 3.73M | 3.74M | 3.79M | 3.80M | 3.69M |
Total Amortization of Deferred Charges | 235.00K | 234.00K | 232.00K | 231.00K | 241.00K |
Total Other Non-Cash Items | 37.12M | 35.55M | 33.62M | 31.50M | 29.36M |
Change in Net Operating Assets | -18.50M | -21.29M | -13.91M | -6.47M | -4.62M |
Cash from Operations | -33.96M | -35.19M | -32.01M | -26.29M | -24.21M |
Capital Expenditure | -2.13M | -1.61M | -1.51M | -2.62M | -2.68M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 16.07M | 6.07M | -5.67M | -107.93M | -148.22M |
Cash from Investing | 13.94M | 4.46M | -7.18M | -110.55M | -150.90M |
Total Debt Issued | -- | -- | -- | -1.09M | -1.09M |
Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
Issuance of Common Stock | 14.25M | 2.78M | 3.89M | 114.55M | 115.76M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | 1.10M | 970.00K |
Cash from Financing | 14.25M | 2.78M | 3.89M | 114.56M | 115.64M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -5.76M | -27.95M | -35.30M | -22.27M | -59.47M |